PK Biosciences Corporation provides research and diagnostic tools for drug discovery and therapeutic development for treatment of neurological and neurodegenerative diseases. The firm is focused on oral medicines that are targeted against selective cell death signaling molecules, which are involved in the cell survival and apoptotic cell death found in Amyotrophic lateral sclerosis, Parkinsonâs, Alzheimerâs and Huntington diseas
